iNeo-Vac-P01

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameiNeo-Vac-P01
Drug Alias NamePersonalized neoantigen cancer vaccineiNeo-Vac-P01
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Neoantigen Therapeutics
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Neoantigen TherapeuticsZhejiang University
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A